title: Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?
abstract: Sepsis is a systemic inflammatory response that follows bacterial infection. Cardiac dysfunction is an important consequence of sepsis that affects mortality and has been attributed to either elevated inflammation or suppression of both fatty acid and glucose oxidation and eventual ATP depletion. Moreover, cardiac adrenergic signaling is compromised in septic patients and this aggravates further heart function. While anti-inflammatory therapies are important for the treatment of the disease, administration of anti-inflammatory drugs did not improve survival in septic patients. This review article summarizes findings on inflammatory and other mechanisms that are triggered in sepsis and affect cardiac function and mortality. Particularly, it focuses on the effects of the disease in metabolic pathways, as well as in adrenergic signaling and the potential interplay of the latter with inflammation. It is suggested that therapeutic approaches should include combination of anti-inflammatory treatments, stimulation of energy production, and restoration of adrenergic signaling in the heart.
authors.affiliation: Metabolic Biology Laboratory, Center for Translational Medicine, Department of Pharmacology, Temple University School of Medicine, 3500 N. Broad Street, MERB-951, Philadelphia, PA, 19140, USA, drosatos@temple.edu.
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Drosatos
authors.forename: Anastasios
authors.initials: A
authors.lastname: Lymperopoulos
authors.forename: Peter Johannes
authors.initials: PJ
authors.lastname: Kennel
authors.forename: Nina
authors.initials: N
authors.lastname: Pollak
authors.forename: P Christian
authors.initials: PC
authors.lastname: Schulze
authors.forename: Ira J
authors.initials: IJ
authors.lastname: Goldberg
mesh_terms: D009202:Cardiomyopathies / Q000503:physiopathology*; D004734:Energy Metabolism; D005227:Fatty Acids / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000503:physiopathology*; D011943:Receptors, Adrenergic, beta / Q000378:metabolism; D018805:Sepsis / Q000503:physiopathology*
chemical_list: D005227:Fatty Acids; D011943:Receptors, Adrenergic, beta